Autosomal Dominant Hypercholesterolemia: Needs for Early Diagnosis and Cascade Screening in the Tunisian Population

Autosomal dominant hypercholesterolemia (ADH) is characterized by an isolated elevation of plasmatic lowdensity lipoprotein (LDL), which predisposes to premature coronary artery disease (CAD) and early death. ADH is largely due to mutations in the low-density lipoprotein receptor gene (LDLR), the ap...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Current genomics 2013-03, Vol.14 (1), p.25-32
Hauptverfasser: Jelassi, Awatef, Najah, Mohamed, Slimani, Afef, Jguirim, Imen, Slimane, Mohamed Naceur, Varret, Mathilde
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 32
container_issue 1
container_start_page 25
container_title Current genomics
container_volume 14
creator Jelassi, Awatef
Najah, Mohamed
Slimani, Afef
Jguirim, Imen
Slimane, Mohamed Naceur
Varret, Mathilde
description Autosomal dominant hypercholesterolemia (ADH) is characterized by an isolated elevation of plasmatic lowdensity lipoprotein (LDL), which predisposes to premature coronary artery disease (CAD) and early death. ADH is largely due to mutations in the low-density lipoprotein receptor gene (LDLR), the apolipoprotein B-100 gene (APOB), or the proprotein convertase subtilisin/kexin type 9 (PCSK9). Early diagnosis and initiation of treatment can modify the disease progression and its outcomes. Therefore, cascade screening protocol with a combination of plasmatic lipid measurements and DNA testing is used to identify relatives of index cases with a clinical diagnosis of ADH. In Tunisia, an attenuated phenotypic expression of ADH was previously reported, indicating that the establishment of a special screening protocol is necessary for this population.
doi_str_mv 10.2174/138920213804999200
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3580777</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1429630507</sourcerecordid><originalsourceid>FETCH-LOGICAL-b439t-8860dc25b35f1b8c2e034f38f254c7a13cff2df90210cb2f083d19e52b92a2033</originalsourceid><addsrcrecordid>eNqNkc1u1DAUhSMEoqXwAiyQl2wGHNuZ2CyQqmlLkSpAoqytG-dmYnDsYDsdzZYnx9W0FYgNq3tkf-fo_lTVy5q-YXUr3tZcKkZZKVQoVSR9VB3Xsm1WjZDycdEFWBVCHVXPUvpOKaOypU-rI8aVatdCHlfpdMkhhQkcOQuT9eAzudzPGM0YHKaMsZTJwjvyCbFPZAiRnEN0e3JmYetDsomA78kGkoEeyVcTEb31W2I9ySOS68XbZMGTL2FeHGQb_PPqyQAu4Yu7elJ9uzi_3lyurj5_-Lg5vVp1gqu8knJNe8OajjdD3UnDkHIxcDmwRpgWam6GgfWDKhugpmMDlbyvFTasUwwY5fyken_InZduwt6gzxGcnqOdIO51AKv__vF21Ntwo3kjadu2JeD1XUAMP5eyDT3ZZNA58BiWpGvB1JrThv4HyoUUinIpCsoOqIkhpYjDQ0c11beH1f8etphe_TnLg-X-kgX4dQC6MswIUzIWvcEHcMx51rvdTuMS8QckdGiyNmHSYUa_RFe0z8Wr53HWW_QRNcRsjUNtU_L3TSl9E9wyYRn-9n0pQqcZtqhZw38DWwLSXQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1348490384</pqid></control><display><type>article</type><title>Autosomal Dominant Hypercholesterolemia: Needs for Early Diagnosis and Cascade Screening in the Tunisian Population</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Jelassi, Awatef ; Najah, Mohamed ; Slimani, Afef ; Jguirim, Imen ; Slimane, Mohamed Naceur ; Varret, Mathilde</creator><creatorcontrib>Jelassi, Awatef ; Najah, Mohamed ; Slimani, Afef ; Jguirim, Imen ; Slimane, Mohamed Naceur ; Varret, Mathilde</creatorcontrib><description>Autosomal dominant hypercholesterolemia (ADH) is characterized by an isolated elevation of plasmatic lowdensity lipoprotein (LDL), which predisposes to premature coronary artery disease (CAD) and early death. ADH is largely due to mutations in the low-density lipoprotein receptor gene (LDLR), the apolipoprotein B-100 gene (APOB), or the proprotein convertase subtilisin/kexin type 9 (PCSK9). Early diagnosis and initiation of treatment can modify the disease progression and its outcomes. Therefore, cascade screening protocol with a combination of plasmatic lipid measurements and DNA testing is used to identify relatives of index cases with a clinical diagnosis of ADH. In Tunisia, an attenuated phenotypic expression of ADH was previously reported, indicating that the establishment of a special screening protocol is necessary for this population.</description><identifier>ISSN: 1389-2029</identifier><identifier>EISSN: 1875-5488</identifier><identifier>DOI: 10.2174/138920213804999200</identifier><identifier>PMID: 23997648</identifier><language>eng</language><publisher>United Arab Emirates: Bentham Science Publishers Ltd</publisher><ispartof>Current genomics, 2013-03, Vol.14 (1), p.25-32</ispartof><rights>2013 Bentham Science Publishers 2013</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580777/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580777/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23997648$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jelassi, Awatef</creatorcontrib><creatorcontrib>Najah, Mohamed</creatorcontrib><creatorcontrib>Slimani, Afef</creatorcontrib><creatorcontrib>Jguirim, Imen</creatorcontrib><creatorcontrib>Slimane, Mohamed Naceur</creatorcontrib><creatorcontrib>Varret, Mathilde</creatorcontrib><title>Autosomal Dominant Hypercholesterolemia: Needs for Early Diagnosis and Cascade Screening in the Tunisian Population</title><title>Current genomics</title><addtitle>CG</addtitle><description>Autosomal dominant hypercholesterolemia (ADH) is characterized by an isolated elevation of plasmatic lowdensity lipoprotein (LDL), which predisposes to premature coronary artery disease (CAD) and early death. ADH is largely due to mutations in the low-density lipoprotein receptor gene (LDLR), the apolipoprotein B-100 gene (APOB), or the proprotein convertase subtilisin/kexin type 9 (PCSK9). Early diagnosis and initiation of treatment can modify the disease progression and its outcomes. Therefore, cascade screening protocol with a combination of plasmatic lipid measurements and DNA testing is used to identify relatives of index cases with a clinical diagnosis of ADH. In Tunisia, an attenuated phenotypic expression of ADH was previously reported, indicating that the establishment of a special screening protocol is necessary for this population.</description><issn>1389-2029</issn><issn>1875-5488</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNqNkc1u1DAUhSMEoqXwAiyQl2wGHNuZ2CyQqmlLkSpAoqytG-dmYnDsYDsdzZYnx9W0FYgNq3tkf-fo_lTVy5q-YXUr3tZcKkZZKVQoVSR9VB3Xsm1WjZDycdEFWBVCHVXPUvpOKaOypU-rI8aVatdCHlfpdMkhhQkcOQuT9eAzudzPGM0YHKaMsZTJwjvyCbFPZAiRnEN0e3JmYetDsomA78kGkoEeyVcTEb31W2I9ySOS68XbZMGTL2FeHGQb_PPqyQAu4Yu7elJ9uzi_3lyurj5_-Lg5vVp1gqu8knJNe8OajjdD3UnDkHIxcDmwRpgWam6GgfWDKhugpmMDlbyvFTasUwwY5fyken_InZduwt6gzxGcnqOdIO51AKv__vF21Ntwo3kjadu2JeD1XUAMP5eyDT3ZZNA58BiWpGvB1JrThv4HyoUUinIpCsoOqIkhpYjDQ0c11beH1f8etphe_TnLg-X-kgX4dQC6MswIUzIWvcEHcMx51rvdTuMS8QckdGiyNmHSYUa_RFe0z8Wr53HWW_QRNcRsjUNtU_L3TSl9E9wyYRn-9n0pQqcZtqhZw38DWwLSXQ</recordid><startdate>201303</startdate><enddate>201303</enddate><creator>Jelassi, Awatef</creator><creator>Najah, Mohamed</creator><creator>Slimani, Afef</creator><creator>Jguirim, Imen</creator><creator>Slimane, Mohamed Naceur</creator><creator>Varret, Mathilde</creator><general>Bentham Science Publishers Ltd</general><general>Bentham Science Publishers</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201303</creationdate><title>Autosomal Dominant Hypercholesterolemia: Needs for Early Diagnosis and Cascade Screening in the Tunisian Population</title><author>Jelassi, Awatef ; Najah, Mohamed ; Slimani, Afef ; Jguirim, Imen ; Slimane, Mohamed Naceur ; Varret, Mathilde</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b439t-8860dc25b35f1b8c2e034f38f254c7a13cff2df90210cb2f083d19e52b92a2033</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jelassi, Awatef</creatorcontrib><creatorcontrib>Najah, Mohamed</creatorcontrib><creatorcontrib>Slimani, Afef</creatorcontrib><creatorcontrib>Jguirim, Imen</creatorcontrib><creatorcontrib>Slimane, Mohamed Naceur</creatorcontrib><creatorcontrib>Varret, Mathilde</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Current genomics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jelassi, Awatef</au><au>Najah, Mohamed</au><au>Slimani, Afef</au><au>Jguirim, Imen</au><au>Slimane, Mohamed Naceur</au><au>Varret, Mathilde</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Autosomal Dominant Hypercholesterolemia: Needs for Early Diagnosis and Cascade Screening in the Tunisian Population</atitle><jtitle>Current genomics</jtitle><addtitle>CG</addtitle><date>2013-03</date><risdate>2013</risdate><volume>14</volume><issue>1</issue><spage>25</spage><epage>32</epage><pages>25-32</pages><issn>1389-2029</issn><eissn>1875-5488</eissn><abstract>Autosomal dominant hypercholesterolemia (ADH) is characterized by an isolated elevation of plasmatic lowdensity lipoprotein (LDL), which predisposes to premature coronary artery disease (CAD) and early death. ADH is largely due to mutations in the low-density lipoprotein receptor gene (LDLR), the apolipoprotein B-100 gene (APOB), or the proprotein convertase subtilisin/kexin type 9 (PCSK9). Early diagnosis and initiation of treatment can modify the disease progression and its outcomes. Therefore, cascade screening protocol with a combination of plasmatic lipid measurements and DNA testing is used to identify relatives of index cases with a clinical diagnosis of ADH. In Tunisia, an attenuated phenotypic expression of ADH was previously reported, indicating that the establishment of a special screening protocol is necessary for this population.</abstract><cop>United Arab Emirates</cop><pub>Bentham Science Publishers Ltd</pub><pmid>23997648</pmid><doi>10.2174/138920213804999200</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1389-2029
ispartof Current genomics, 2013-03, Vol.14 (1), p.25-32
issn 1389-2029
1875-5488
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3580777
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
title Autosomal Dominant Hypercholesterolemia: Needs for Early Diagnosis and Cascade Screening in the Tunisian Population
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T18%3A59%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Autosomal%20Dominant%20Hypercholesterolemia:%20Needs%20for%20Early%20Diagnosis%20and%20Cascade%20Screening%20in%20the%20Tunisian%20Population&rft.jtitle=Current%20genomics&rft.au=Jelassi,%20Awatef&rft.date=2013-03&rft.volume=14&rft.issue=1&rft.spage=25&rft.epage=32&rft.pages=25-32&rft.issn=1389-2029&rft.eissn=1875-5488&rft_id=info:doi/10.2174/138920213804999200&rft_dat=%3Cproquest_pubme%3E1429630507%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1348490384&rft_id=info:pmid/23997648&rfr_iscdi=true